DUOHEXABODY
LIVE

Serial Number

79253337

Owner

Genmab Holding B.V.

Attorney

Max Vern

Filing Date

Nov 15, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DUOHEXABODY Trademark

Serial Number: 79253337 • Registration: 5993053

DUOHEXABODY is a trademark filed by Genmab Holding B.V. on November 15, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Genmab Holding B.V.

Uppsalalaan 15

Entity Type: 16

Trademark Details

Filing Date

November 15, 2018

Registration Date

February 25, 2020

Published for Opposition

December 10, 2019

Goods & Services

[ Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, and derivatives or conjugates of any of these, for in vitro and in vivo scientific and industrial research and development with regard to diseases; Active chemical ingredients for use in the manufacture of pharmaceuticals ]

[ Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases ]

Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these

[ Legal services in the field of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 16, 2026 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jun 16, 2026 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 15, 2026 APRE
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Mar 5, 2026 RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Mar 5, 2026 RHRD
TEAS SECTION 71 RECEIVED
Feb 24, 2026 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Apr 24, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 25, 2025 REM3
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 5, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 10, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 22, 2020 FICS
FINAL DISPOSITION PROCESSED
Jun 22, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 25, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2019 NONP
ASSIGNED TO LIE
Nov 5, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2019 CNSA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Oct 31, 2019 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 19, 2019 CRCV
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 13, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 13, 2019 GNSL
SUSPENSION LETTER WRITTEN
Sep 13, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 12, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 28, 2019 REPR